# InteKrin Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/intekrin-therapeutics

- Industry: Biotechnology
- Headquarters: Los Altos, US
- Website: www.intekrin.com
- Total disclosed funding: $42M
- Latest round: Series C (Aug 4, 2008)
- Investors on record: 8

## About

InteKrin Therapeutics is based in US and operates as a clinical stage bio-pharmaceutical company.

## Funding rounds

- Series C, Aug 4, 2008, $19M — OrbiMed Advisors, Sofinnova Investments, Skyline Ventures, Amgen Ventures, Vivo Capital, Asset Management Ventures, Sears Capital Management
- Series B, Jan 11, 2007, $23M — OrbiMed Advisors, Sofinnova Investments, Vivo Capital, Asset Management, Sears Capital Management

## Investors

- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series B, Series C
- Sofinnova Investments (https://capitalatlas.ai/funds/sofinnova-investments) — Series B, Series C
- Vivo Capital (https://capitalatlas.ai/funds/vivo-capital) — Series B, Series C
- Asset Management — Series B
- Sears Capital Management (https://capitalatlas.ai/funds/sears-capital-management) — Series B, Series C
- Skyline Ventures (https://capitalatlas.ai/funds/skyline-ventures) — Series C
- Amgen Ventures (https://capitalatlas.ai/funds/amgen-ventures) — Series C
- Asset Management Ventures (https://capitalatlas.ai/funds/asset-management-ventures) — Series C